AZA has been used for the treatment of autoimmune and rheumatic diseases; however, only a few observational studies and case reports have examined patients with these diseases who developed AZA-induced toxicities associated with the NUDT15 variants. This evidence concerns the gene NUDT15 and rheumatic disorder.